Cover Image

Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers

Background and Objective: Inhibition of thrombosis and platelet aggregation through a thromboxane synthetase inhibitor proved to be an effective and promising treatment for cardiovascular and/or cerebrovascular disease (CCVD) patients. This phase I study evaluated the safety, tolerability, and pharm...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chan Zou (Author), Xiaocong Zuo (Author), Jie Huang (Author), Ye Hua (Author), Shuang Yang (Author), Xiaoyan Yang (Author), Can Guo (Author), Hongyi Tan (Author), Jun Chen (Author), Zhaoxing Chu (Author), Qi Pei (Author), Guoping Yang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2019-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Semi-Mechanistic Modeling of HY-021068 Based on Irreversible Inhibition of Thromboxane Synthetase
by: Ping Li, et al.
Published: (2020)

Thromboxane Modulates Endothelial Permeability
by: J. M. Klausner, et al.
Published: (1994)

Measurement of Thromboxane Biosynthesis in Health and Disease
by: Carlo Patrono, et al.
Published: (2019)

Foetal vascular responses to thromboxane receptor blockade
by: B. A. Meyer, et al.
Published: (1992)

Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
by: Mohammad Al‐Mahdi Al‐Karagholi, et al.
Published: (2021)

Evaluation of NTP42, a novel thromboxane receptor antagonist, in a first-in-human phase I clinical trial
by: Helen M. Reid, et al.
Published: (2023)

Physiological Significance of Thromboxane A2 Receptor Dimerization
by: Masako Sasaki, et al.
Published: (2006)

Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC‐0214 in healthy volunteers
by: Rui Zhu, et al.
Published: (2022)

The regulatory roles of aminoacyl-tRNA synthetase in cardiovascular disease
by: Yulin Zou, et al.
Published: (2021)

Thromboxane-induced contractile response of mesenteric arterioles is diminished in the older rats and the older hypertensive rats
by: Min Zhang, et al.
Published: (2022)

A randomized, double-blind, parallel control study to evaluate the biosimilarity of QL1209 with Perjeta® in healthy male subjects
by: Yuanyuan Sun, et al.
Published: (2022)

Effect of Probenecid on Pharmacokinetics and Tolerability of Olmesartan in Healthy Chinese Volunteers
by: Kun-Yan Li, PhD, et al.
Published: (2014)

Kallistatin leads to cognition impairment via downregulating glutamine synthetase
by: Yanlan Long, et al.
Published: (2024)

Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects
by: Min Young Park, et al.
Published: (2023)

Prostaglandin cyclooxygenase products but not thromboxane A2 are involved in the pathogenesis of ewthromelalgia in thrombocythaemia
by: J. J. Michiels, et al.
Published: (1993)

Effect of CYP4F2 Polymorphisms on Ticagrelor Pharmacokinetics in Healthy Chinese Volunteers
by: Shanshan Nie, et al.
Published: (2022)

Safety and Tolerability of KIO-101 Eye Drops in Healthy Volunteers and Patients with Ocular Surface Disease-A Phase I Study
by: Doreen Schmidl, et al.
Published: (2024)

A Randomized Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Erwinia Asparaginase (JZP‐458) in Healthy Adult Volunteers
by: Tong Lin, et al.
Published: (2021)

Cutaneous manifestations of anti‐synthetase syndrome: Case series and literature review
by: Airiss R. Chan, et al.
Published: (2024)

Anti-thromboxane B2 antibodies protect against acetaminophen-induced liver injury in mice
by: Ivan Ćavar, et al.
Published: (2011)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers
by: Desmond Y. H. Yap, et al.
Published: (2021)

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers
by: Marie A. Printz, BA, et al.
Published: (2020)

Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of the QX002N anti-IL-17 Monoclonal Antibody: A Phase I, Randomized, Double-Blind, Single Ascending Dose Study in Healthy Chinese Volunteers
by: Min Wu, et al.
Published: (2022)

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese Subjects
by: Ma J, et al.
Published: (2023)

Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers
by: Lulu Chen, et al.
Published: (2018)

The safety and tolerability of alkaloids from Alstonia scholaris leaves in healthy Chinese volunteers: a single-centre, randomized, double-blind, placebo-controlled phase I clinical trial
by: Zhong-Ping Gou, et al.
Published: (2021)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a soluble guanylate cyclase stimulator, HEC95468, in healthy volunteers: a randomized, double-blinded, placebo-controlled phase 1 trial
by: Yu-zhou Gui, et al.
Published: (2024)

A Phase I, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Tolerance of Oil Palm Phenolics (OPP) in Healthy Volunteers
by: Nur Balqis Muhammad Ismail Tadj, et al.
Published: (2022)

Safety, tolerance, and pharmacokinetics of salvianolic acid B in healthy Chinese volunteers: A randomized, double-blind, placebo-controlled phase 1 clinical trial
by: Junlin Cheng, et al.
Published: (2023)

Evaluation of the safety, tolerability, and pharmacokinetics of RO7049389 in healthy Chinese volunteers
by: Xiaojie Wu, et al.
Published: (2022)

Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers
by: Himanshu Naik, et al.
Published: (2021)

The problem of over-volunteering in early phase clinical trials
by: S. B. Fitilev, et al.
Published: (2018)

High-Glucose Enhances a Thromboxane A2-Induced Aortic Contraction Mediated by an Alteration of Phosphatidylinositol Turnover
by: Koji Nobe, et al.
Published: (2003)

Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation
by: Giovanna Petrucci, et al.
Published: (2022)

Selective inhibition by antiflamrnin-2 of thromboxane B2 release from isolated and perfused guinea-pig lung
by: Lidia Sautebin, et al.
Published: (1992)

Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers
by: Xiaojiao Li, et al.
Published: (2018)

Factors Associated with Aspirin Resistance in Hong Kong Chinese Patients with Stable Coronary Heart Disease Using the Multiplate<sup>®</sup> Analyzer and Serum Thromboxane B<sub>2</sub>
by: Weiwei Zeng, et al.
Published: (2022)

Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screening
by: Diego Benítez, et al.
Published: (2022)

Pharmacokinetics, pharmacodynamics, and safety of frunexian in healthy Chinese volunteer adults: A randomized dose‐escalation phase I study
by: Jia‐yu Zhang, et al.
Published: (2024)

Clinical features and CPS1 variants in Chinese patients with carbamoyl phosphate synthetase 1 deficiency
by: Hui Dong, et al.
Published: (2024)